Skip to content
Open access

Characteristics and outcomes of adult patients hospitalised with RSV infection, influenza or COVID-19 in Belgium, winter seasons 2023/24 and 2024/25

Sep 2026 · Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · Vol 31 · 0 citations · 39 references
Medicine

TL;DR

Patients with RSV infection had a disease course comparable to patients with influenza or COVID-19 and a higher mortality rate, especially with increasing age, highlighting the importance of RSV vaccination in older adults and those with comorbidities, alongside established vaccination strategies for seasonal influenza and COVID-19.

Abstract

Background

Severe acute respiratory infections (SARI) cause substantial disease burden in older adults and those with comorbidities.

Aim

To inform Belgian vaccination policies, we aimed to compare risk profiles and outcomes of influenza, COVID-19 and RSV infections and examine age-related differences.

Methods

Adults (≥ 18 years) hospitalised with SARI in nine Belgian sentinel hospitals during the 2023/24 and 2024/25 winter seasons were included. Patients with laboratory-confirmed RSV infection, influenza or COVID-19 were compared in terms of demographics, comorbidities, complications and outcomes. Adults 18–64 years were compared with those ≥ 65 years. Multivariate analyses were applied.

Results

Among 2,806 patients, 535 (19.1%) had RSV infection, 1,694 (60.4%) influenza and 577 (20.6%) COVID-19. Patients with influenza were significantly younger (mean age 68.9 years) and had significantly fewer comorbidities (89.7%) than patients with RSV (73.8 years; 95.8%) or COVID-19 (74.0 years; 93.6%). Patients with COVID-19 experienced significantly fewer complications (40.8%) than patients with RSV (48.9%) or influenza (45.2%). Patients with RSV had higher in-hospital mortality (11.9%) than patients with influenza (7.3%; p = 0.089) or COVID-19 (6.9%; p = 0.037). Across pathogens, younger adults had relatively more comorbidities after adjusting for differences in the general population. They had shorter hospital stays and lower mortality, but higher intensive care unit admission rates.

Conclusion

Patients with RSV infection had a disease course comparable to patients with influenza or COVID-19 and a higher mortality rate, especially with increasing age. These findings highlight the importance of RSV vaccination in older adults and those with comorbidities, alongside established vaccination strategies for seasonal influenza and COVID-19.

Read PDF

Similar papers

Open access Aug 2026

Comparison of Clinical Outcomes Associated with RSV and Influenza Infections in Adults: A Multicenter Study from Türkiye (For AP-TR).

OBJECTIVES Respiratory syncytial virus (RSV) is an increasingly recognized cause of serious respiratory illness in adults, yet data from middle-income countries remain scarce. This study aimed to compare clinical outcomes of RSV and influenza virus infections in hospitalized and outpatient adults in Türkiye. METHODS...

Irem Akdemir, Hasan Selçuk Özger, Tugba Akkaya Hocagil et al. · 0 citations
Open access Aug 2026

Association between influenza vaccination and severe outcomes in adults aged ≥ 65 years hospitalized with laboratory-confirmed influenza: a retrospective cohort study, I-MOVE hospital network, Europe, 2015/16-2024/25.

Vaccination showed little or no association with ICU admission, but was associated with a one-quarter reduction in IHD among hospitalized older adults, reinforcing its benefits against fatal in-hospital outcomes.

Diogo F. P. Marques, Angela M. C. Rose, S. Monge et al. · 0 citations
Open access Sep 2026

Surveillance for severe influenza, COVID-19, and RSV in patients admitted to sentinel Australian hospitals in 2025: the Influenza Complications Alert Network (FluCAN) and the Paediatric Active Enhanced Disease Surveillance (PAEDS) system.

Assessment of vaccine effectiveness demonstrated protection against influenza hospitalisation and short-term protection against hospitalisation with COVID-19 in older people.

Hannah J. Morgan, Dominic E. Dwyer, Mark Holmes et al. · 0 citations
Open access Sep 2026

Comparative Burden of COVID-19 in Adults with Rheumatic Diseases and Immunocompetent Individuals: A Population-Based Cohort Study in Quebec, Canada, 2020-2023

Individuals with SARDs, especially receiving highly immunosuppressive therapies, experienced elevated COVID-19 burden and severe outcome risks throughout the pandemic, warranting their prioritized consideration during future public health emergencies.

S. Carazo, I. Colmegna, S. Bernatsky et al. · 0 citations
Open access Oct 2026

COVID-19 vaccination is associated with lower mortality and intensive care unit admission among hospitalized patients with COVID-19: A retrospective cohort study

Background: The development of vaccines has played a significant role in managing the pandemic of COVID-19. The objective of this study was to investigate the impact of COVID-19 vaccination on mortality and intensive care unit (ICU) admissions. Methods: This retrospective, single-center cohort study included hospitaliz...

Julian Madrid · 0 citations
Review Open access Sep 2026

High Mortality in Adults With Community-Acquired Pneumonia Admitted to Hospitals in South Africa Before and During the COVID-19 Pandemic, Stratified by HIV Serostatus and Viral Load: Data From a Prospective Cohort Study (2019–2021)

In-hospital and postdischarge community-acquired pneumonia mortality remains high, particularly among PWH, regardless of virologic status, warranting urgent investigation of mitigation strategies.

N. Sabet, Firdaus Nabeemeeah, K. Otwombe et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.